by thaan@22fillmore | Jun 4, 2025
Chris Hite brings over 25 years of financial and strategic experience in the biopharmaceutical industry this role as an independent board member and audit committee chair. He currently serves as Executive Vice President and Vice Chairman at Royalty Pharma. Prior to...
by thaan@22fillmore | May 1, 2025
Adam Koppel is a Partner at Bain Capital Life Sciences. He initially joined Bain Capital Public Equity in 2003, where he was a leader within the healthcare sector until 2014. From 2014 to 2016, he was EVP of Corporate Development and Chief Strategy Officer at Biogen....
by Siro Solutions Dev | Sep 19, 2024
Amir Zamani is a Managing Director at Bain Capital Life Sciences and leads investments in biopharmaceutical, medical device, and diagnostics companies. He currently serves as a board observer at Rivus Pharmaceuticals. He previously served as a board member at Aiolos...
by Siro Solutions Dev | Sep 11, 2024
Ron Renaud is Kailera’s President and Chief Executive Officer. Prior to joining Kailera, Ron served as Cerevel Therapeutics’ President and Chief Executive Officer, where he guided the company through significant milestones, culminating in its acquisition by...
by Siro Solutions Dev | Sep 11, 2024
Michael Gladstone is a partner at Atlas Venture and focuses on building new therapeutics companies. Michael is a co-founder and board member of Diagonal Therapeutics and Third Harmonic Bio (NASDAQ: THRD), and a board member of Day One Biopharmaceuticals (NASDAQ:...
